-
-
-
-
-
-
-
FibroBiologics (FBLG) PT Lowered to $6 at H.C. Wainwright
-
-
-
-
-
-
-
FibroBiologics terminates Texas sublease early, saves $0.8 million
-
-
-
-
-
-
-
FibroBiologics receives Canadian patent for cachexia treatment
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on FibroBiologics (FBLG)
-
-
-
-
-
-
-
FibroBiologics reports progress in bone marrow organoid development
-
-
-
-
-
-
-
FibroBiologics (FBLG) Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics
-
-
-
-
-
-
-
H.C. Wainwright Starts FibroBiologics (FBLG) at Buy
-
479,028 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


